Liztox® 100U – Premium Botulinum Toxin Type A
Developed by Huons Global (KOSDAQ: 243070), Liztox® contains 900kDa neurotoxin with 99.8% purity. FDA-approved manufacturing process ensures precise 100U/vial potency. Clinically proven to reduce dynamic wrinkles within 72-120 hours, lasting 2-8 months based on 2023 multicenter trials.
KEY ADVANTAGES
• 99.8% Active Toxin Purity
• 3-7 Day Onset Period
• CBFC26 Strain Specificity
• 0.01% HSA Content
• 2.5ml/5ml Dilution Flexibility
• 40-60U Facial Dose Range
• 100U Per Vial Standardization
• ISO 13485 Certified
PRODUCTION TECHNOLOGY
• Clostridium Botulinum CBFC26 strain cultivation
• Chromatographic purification (≥3 stages)
• Lyophilized stabilization with 0.5mg HSA
• Terminal sterilization (121°C, 15min)
PACKAGING SPECIFICATIONS
• 100U ± 5% potency guarantee
• HDPE container system
• -20°C long-term storage
CLINICAL PROTOCOL
1. Reconstitute with sterile saline (0.9% NaCl)
2. Maintain 2-8°C post-reconstitution
3. Use 30G/32G needles for injection
4. Max 50U per treatment site
5. 3-month minimum reinjection interval
*For licensed practitioners only. Not FDA-approved for all indications. Individual results may vary ±20% based on injection technique and patient metabolism. Contraindicated in neuromuscular disorders. HCP License Required. Batch-specific potency verification mandatory prior to administration.
Reviews
There are no reviews yet.